A detailed history of Geode Capital Management, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 597,188 shares of BMEA stock, worth $5.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
597,188
Previous 493,631 20.98%
Holding current value
$5.3 Million
Previous $7.38 Million 63.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$4.14 - $15.3 $428,725 - $1.58 Million
103,557 Added 20.98%
597,188 $2.69 Million
Q1 2024

May 13, 2024

BUY
$13.92 - $19.5 $185,261 - $259,525
13,309 Added 2.77%
493,631 $7.38 Million
Q4 2023

Feb 13, 2024

BUY
$8.37 - $19.8 $226,667 - $536,203
27,081 Added 5.97%
480,322 $6.97 Million
Q3 2023

Nov 13, 2023

BUY
$13.44 - $23.02 $308,380 - $528,193
22,945 Added 5.33%
453,241 $6.24 Million
Q2 2023

Aug 11, 2023

BUY
$21.66 - $41.8 $4.72 Million - $9.11 Million
218,011 Added 102.7%
430,296 $9.44 Million
Q1 2023

May 15, 2023

BUY
$6.8 - $32.35 $339,986 - $1.62 Million
49,998 Added 30.81%
212,285 $6.58 Million
Q4 2022

Feb 13, 2023

SELL
$6.3 - $11.6 $2,173 - $4,002
-345 Reduced 0.21%
162,287 $1.37 Million
Q3 2022

Nov 14, 2022

BUY
$9.51 - $13.61 $685,537 - $981,090
72,086 Added 79.61%
162,632 $1.59 Million
Q2 2022

Aug 12, 2022

SELL
$3.0 - $12.03 $480,165 - $1.93 Million
-160,055 Reduced 63.87%
90,546 $1.08 Million
Q1 2022

May 13, 2022

BUY
$4.39 - $9.03 $100,122 - $205,947
22,807 Added 10.01%
250,601 $1.12 Million
Q4 2021

Feb 11, 2022

BUY
$7.22 - $12.72 $527,579 - $929,475
73,072 Added 47.23%
227,794 $1.7 Million
Q3 2021

Nov 12, 2021

BUY
$10.0 - $15.99 $104,610 - $167,271
10,461 Added 7.25%
154,722 $1.85 Million
Q2 2021

Aug 13, 2021

BUY
$13.65 - $20.93 $1.97 Million - $3.02 Million
144,261 New
144,261 $2.25 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $260M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.